Luminex Corp

Find Ratings Reports
LMNX : NASDAQ : Health Care
$19.91 | %
Today's Range: 19.71 - 20.01
Avg. Daily Volume: 220700.0
01/20/17 - 4:00 PM ET

Financial Analysis


LUMINEX CORP's gross profit margin for the third quarter of its fiscal year 2016 has decreased when compared to the same period a year ago. Even though sales increased, the net income has decreased. LUMINEX CORP is extremely liquid. Currently, the Quick Ratio is 3.61 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.

During the same period, stockholders' equity ("net worth") has increased by 17.59% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q3 FY16 Q3 FY15
Net Sales ($mil)71.2260.6
EBITDA ($mil)10.4213.12
EBIT ($mil)4.519.71
Net Income ($mil)2.756.4


Balance Sheet Q3 FY16 Q3 FY15
Cash & Equiv. ($mil)84.15131.56
Total Assets ($mil)441.13376.33
Total Debt ($mil)0.00.0
Equity ($mil)402.77342.51


Profitability Q3 FY16 Q3 FY15
Gross Profit Margin68.9373.34
EBITDA Margin14.6321.64
Operating Margin6.3316.02
Sales Turnover0.590.63
Return on Assets8.5110.43
Return on Equity9.3211.47
Debt Q3 FY16 Q3 FY15
Current Ratio5.227.57
Debt/Capital0.00.0
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q3 FY16 Q3 FY15
Shares outstanding (mil)42.7142.17
Div / share0.00.0
EPS0.060.15
Book value / share9.438.12
Institutional Own % n/a n/a
Avg Daily Volume216713.0194863.0

Valuation


BUY. The current P/E ratio indicates a significant discount compared to an average of 37.48 for the Life Sciences Tools & Services industry and a value on par with the S&P 500 average of 25.49. To use another comparison, its price-to-book ratio of 2.17 indicates a discount versus the S&P 500 average of 2.84 and a significant discount versus the industry average of 5.58. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. Upon assessment of these and other key valuation criteria, LUMINEX CORP proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
LMNX 23.54 Peers 37.48   LMNX 17.78 Peers 23.16

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

LMNX is trading at a significant discount to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

LMNX is trading at a discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
LMNX 46.55 Peers 26.73   LMNX NM Peers 1.70

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

LMNX is trading at a significant premium to its peers.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

LMNX's negative PEG ratio makes this valuation measure meaningless.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
LMNX 2.17 Peers 5.58   LMNX -5.44 Peers 4.07

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

LMNX is trading at a significant discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, LMNX is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
LMNX 3.38 Peers 32.28   LMNX 9.96 Peers 9.18

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

LMNX is trading at a significant discount to its industry on this measurement.

 

Average. Comparing a company's sales growth to its industry helps to determine if the company is adding or losing market share.

LMNX is keeping pace with its peers on the basis of sales growth.

 

 

Latest Stock Upgrades/Downgrades